{"url_path":"/sec/aspi/8-k/2026-06-25/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 ** **Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-25","source_url":"https://www.sec.gov/Archives/edgar/data/1921865/0001477932-26-004020-index.html","accession_number":"0001477932-26-004020","cik":"0001921865","ticker":"ASPI","issuer_name":"ASP Isotopes Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1921865/0001477932-26-004020-index.html","primary_entity_key":"0001921865","primary_entity_name":"ASP Isotopes Inc."},"word_count":182,"has_tables":true,"body_markdown":"**Item 9.01.** **Financial Statements and Exhibits.** \n\n \n\n(d) Exhibits.\n\n \n\n**Exhibit Number**\n\n \n\n**Description**\n\n[2.1*](aspi_ex21.htm)\n\n \n\n[Agreement and Plan of Merger, dated as of June 25, 2026, by and among ENDRA Life Sciences Inc., Kruger Merger Sub LLC, Renergen Limited, Noble Africa LLC and ASP Isotopes Inc.](aspi_ex21.htm)\n\n[10.1](aspi_ex101.htm)\n\n \n\n[Form of Subscription Agreement.](aspi_ex101.htm)\n\n[10.2](aspi_ex102.htm)\n\n \n\n[Form of Pre-Funded Warrant.](aspi_ex102.htm)\n\n[10.3](aspi_ex103.htm)\n\n \n\n[Form of Voting Agreement.](aspi_ex103.htm)\n\n[99.1](aspi_ex991.htm)\n\n \n\n[Form of A&R Certificate of Incorporation.](aspi_ex991.htm)\n\n[99.2**](aspi_ex992.htm)\n\n \n\n[Joint Press Release, issued on June 25, 2026.](aspi_ex992.htm)\n\n[99.3**](aspi_ex993.htm)\n\n \n\n[Renergen Investor Presentation.](aspi_ex993.htm)\n\n104\n\n \n\nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\n \n\n*\n\nCertain schedules, annexes and exhibits have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company will furnish copies of any such schedules, annexes and exhibits to the SEC upon request.\n\n \n\n**\n\nFurnished, not filed.\n\n \n\n \n\n9\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n**ASP ISOTOPES INC.**\n\n \n\n \n\n \n\n \n\n \n\nDate: June 25, 2026\n\nBy:\n\n*/s/ Donald G. Ainscow*\n\n \n\n \n\nName:\n\nDonald G. Ainscow\n\n \n\n \n\nTitle:\n\nExecutive Vice President,\n\nGeneral Counsel and Secretary\n\n \n\n \n\n \n\n10"}